Legal Representation
Attorney
Tricia L. Schulz
USPTO Deadlines
Application History
36 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 16, 2024 | EXT5 | S | SOU EXTENSION 5 FILED |
| Jul 16, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Jul 16, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Feb 9, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Feb 7, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Feb 7, 2024 | EXT4 | S | SOU EXTENSION 4 FILED |
| Feb 7, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 3, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sep 29, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Sep 29, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
| Sep 29, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 12, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 10, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Apr 10, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
| Apr 10, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 3, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Nov 3, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Nov 3, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Oct 6, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 4, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Oct 4, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 4, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
| Apr 26, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 1, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 1, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 9, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 21, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jan 18, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jan 18, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jan 18, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jan 18, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jan 10, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 8, 2021 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Aug 9, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| May 10, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"